TScan Therapeutics, Inc. ($TCRX)
Lynx1 Capital Management LP โ 10% Owner
Shares
6,232
Price
$0.90
Total Value
$5,601.94
P&L
+17.9% (+$1,003.98)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Lynx1 Capital Management LP |
|---|---|
| Title | 10% Owner |
| Transaction Date | Dec 23, 2025 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | See footnote |
| Filing Date | Dec 23, 2025 |
| Document Date | Dec 19, 2025 |
| Shares Purchased | 6,232 |
| Price per Share | $0.90 |
| Total Value | $5,601.94 |
| Shares Owned After | 8,019,148 |
| Derivative | No |
| Accession Number | 0000902664-25-005396 |
| Document | View SEC Filing |